HALO Breast Cytological Evaluation Test
The HALO Breast Cytological Evaluation Test has been FDA approved for the collection of nipple aspirate fluid for cytological evaluation. The collected fluid can be used in the determination and/or differentiation of normal versus pre-malignant versus malignant cells.
Incorporating the HALO system into routine practice will enable physicians and patients to monitor cellular changes within breast ducts earlier, before they develop into larger, potentially cancerous lesions that may much later be detected by conventional breast cancer risk assistment modalities like mammography or manual breast examination.
The HALO System is a simple, reliable method for NAF collection. NAF analysis is an objective assessment of a patient's breast health and can detect early warning signs of ductal cellular changes. Regular assessment and tracking of cellular changes in the milk ducts, where most breast cancer begins, enables clinicians and patients to take control of breast health.
The HALO Breast Cytological Evaluation Test is the only fully automated, noninvasive NAF collection system specifically designed for use in a busy primary care setting.
For the clinician:
Click to view
HALO system and components
Back to top